ZIM Laboratories Limited (NSE:ZIMLAB)
India · Delayed Price · Currency is INR 99.50
-0.66 (-0.66%)
May 25, 2026, 9:26 AM IST
ZIM Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 58.38 | 121.65 | 172.46 | 244.35 | 145.5 |
Depreciation & Amortization | 199.78 | 195.23 | 154.76 | 172.02 | 159.99 |
Other Amortization | - | 5.9 | 4.76 | 2.67 | 0.34 |
Loss (Gain) From Sale of Assets | -25.17 | -3.35 | -4.7 | -0.2 | -0.57 |
Asset Writedown & Restructuring Costs | - | 1.37 | - | 6.6 | 0.03 |
Stock-Based Compensation | 11.35 | 13.54 | - | - | - |
Provision & Write-off of Bad Debts | 5.49 | 14.07 | 9.26 | 7.91 | 0.55 |
Other Operating Activities | 85.93 | 166.76 | 94.09 | 70.27 | 120.41 |
Change in Accounts Receivable | 71.28 | -88.89 | -71.37 | 26.95 | -19.9 |
Change in Inventory | -73.05 | -52.07 | -275.57 | 215.78 | -209.37 |
Change in Accounts Payable | 161.34 | 37.34 | 79.08 | -364.66 | 295.07 |
Operating Cash Flow | 495.34 | 411.55 | 162.78 | 381.68 | 492.06 |
Operating Cash Flow Growth | 20.36% | 152.82% | -57.35% | -22.43% | 54.49% |
Capital Expenditures | -443.87 | -407.98 | -739.23 | -366.68 | -152.25 |
Sale of Property, Plant & Equipment | 56.17 | 7.32 | 5.48 | 0.2 | 1.6 |
Investment in Securities | -177.53 | 0.85 | 3.13 | 3.6 | - |
Other Investing Activities | 1.76 | 0.53 | 0.49 | 0.85 | 4.94 |
Investing Cash Flow | -563.48 | -399.27 | -730.13 | -362.04 | -145.71 |
Short-Term Debt Issued | 68.39 | - | 321.55 | 55.92 | - |
Long-Term Debt Issued | 223.34 | 246.24 | 281.47 | 183.53 | 270.7 |
Total Debt Issued | 291.73 | 246.24 | 603.02 | 239.45 | 270.7 |
Short-Term Debt Repaid | - | -25.27 | - | - | -273.79 |
Long-Term Debt Repaid | -254.31 | -189.02 | -146.56 | -173.91 | -311.56 |
Total Debt Repaid | -254.31 | -214.28 | -146.56 | -173.91 | -585.34 |
Net Debt Issued (Repaid) | 37.42 | 31.96 | 456.45 | 65.54 | -314.64 |
Issuance of Common Stock | 350.78 | - | 214.02 | - | - |
Common Dividends Paid | - | -0.57 | -0.49 | -0.59 | -1.68 |
Other Financing Activities | -106.34 | -122.43 | -74.64 | -59.5 | -13.39 |
Financing Cash Flow | 281.86 | -91.05 | 595.34 | 5.46 | -329.71 |
Foreign Exchange Rate Adjustments | 18.03 | 2.23 | 3.8 | 4.9 | 3.64 |
Net Cash Flow | 231.75 | -76.54 | 31.8 | 30 | 20.28 |
Free Cash Flow | 51.48 | 3.57 | -576.45 | 15 | 339.81 |
Free Cash Flow Growth | 1342.31% | - | - | -95.58% | 33.92% |
Free Cash Flow Margin | 1.38% | 0.09% | -15.68% | 0.38% | 10.19% |
Free Cash Flow Per Share | 1.05 | 0.07 | -11.83 | 0.31 | 6.97 |
Cash Interest Paid | 128.95 | 123 | 75.14 | 55.34 | 79.26 |
Cash Income Tax Paid | 37.34 | -10.76 | 25.84 | 71.49 | 4.29 |
Levered Free Cash Flow | -130.62 | -166.64 | -669.13 | -139.27 | 240.6 |
Unlevered Free Cash Flow | -48.11 | -107.44 | -632.37 | -108.2 | 285.4 |
Change in Working Capital | 159.58 | -103.63 | -267.85 | -121.93 | 65.81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.